While recent guidelines focus primarily on treating renal failure populations [2, 3], work from Levin and colleagues describes early changes in mineral metabolism, particularly parathyroid hormone (PTH) concentrations, that are evident in individuals with only moderate kidney disease [4]. The gene discussed is PTH; the disease is kidney failure.